Niek Peter van Til

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsGene and molecular therapyImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 11, 2025
Assessment of Potential Side Effects Related To RAB27A Gene Therapy in Stem Cells.

Özgür Doğuş Erol, Mehmet Emin Şeker, Şimal Şenocak

|Dec 17, 2024
Gene Therapy for Inherited Liver Disease: To Add or to Edit.

Yue Chen, Niek P van Til, Piter J Bosma

|Oct 30, 2024
Correction of Griscelli Syndrome Type 2 causing mutations in the RAB27A gene with CRISPR/Cas9.

Özgür Doğuş Erol, Şimal Şenocak, Burcu Özçimen

|Oct 26, 2024
Assessment of non-myelotoxic agents as a preparatory regimen for hematopoietic stem cell gene therapy.

Mehmet Emin Şeker, Özgür Doğuş Erol, Burcu Pervin

|Nov 25, 2023
Gene and Cellular Therapies for Leukodystrophies.

Fatima Aerts-Kaya, Niek P van Til

|Dec 08, 2020
Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors.

Vania Lo Presti, Frank Buitenwerf, Niek P van Til

Pageof 1